HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intranasal flu vaccine protective against seasonal and H5N1 avian influenza infections.

AbstractBACKGROUND:
Influenza A (flu) virus causes significant morbidity and mortality worldwide, and current vaccines require annual updating to protect against the rapidly arising antigenic variations due to antigenic shift and drift. In fact, current subunit or split flu vaccines rely exclusively on antibody responses for protection and do not induce cytotoxic T (Tc) cell responses, which are broadly cross-reactive between virus strains. We have previously reported that gamma-ray inactivated flu virus can induce cross-reactive Tc cell responses.
METHODOLOGY/PRINCIPAL FINDING:
Here, we report that intranasal administration of purified gamma-ray inactivated human influenza A virus preparations (gamma-Flu) effectively induces heterotypic and cross-protective immunity. A single intranasal administration of gamma-A/PR8[H1N1] protects mice against lethal H5N1 and other heterotypic infections.
CONCLUSIONS/SIGNIFICANCE:
Intranasal gamma-Flu represents a unique approach for a cross-protective vaccine against both seasonal as well as possible future pandemic influenza A virus infections.
AuthorsMohammed Alsharifi, Yoichi Furuya, Timothy R Bowden, Mario Lobigs, Aulikki Koskinen, Matthias Regner, Lee Trinidad, David B Boyle, Arno Müllbacher
JournalPloS one (PLoS One) Vol. 4 Issue 4 Pg. e5336 ( 2009) ISSN: 1932-6203 [Electronic] United States
PMID19401775 (Publication Type: Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Influenza Vaccines
  • RNA, Viral
  • Vaccines, Inactivated
Topics
  • Administration, Intranasal
  • Animals
  • Cross Reactions
  • Female
  • Gamma Rays
  • Humans
  • Influenza A Virus, H1N1 Subtype (genetics, immunology, pathogenicity)
  • Influenza A Virus, H5N1 Subtype (genetics, immunology, pathogenicity)
  • Influenza Vaccines (administration & dosage)
  • Influenza, Human (immunology, prevention & control, virology)
  • Mice
  • Mice, Inbred BALB C
  • RNA, Viral (analysis, genetics)
  • T-Lymphocytes, Cytotoxic (immunology)
  • Vaccination (methods)
  • Vaccines, Inactivated (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: